Your browser doesn't support javascript.
loading
Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study.
Jiguet-Jiglaire, Carine; Boissonneau, Sebastien; Denicolai, Emilie; Hein, Victoria; Lasseur, Romain; Garcia, Josep; Romain, Sylvie; Appay, Romain; Graillon, Thomas; Mason, Warren; Carpentier, Antoine F; Brandes, Alba A; Ouafik, L 'Houcine; Wick, Wolfgang; Baaziz, Ania; Gigan, Julien P; Argüello, Rafael J; Figarella-Branger, Dominique; Chinot, Olivier; Tabouret, Emeline.
Afiliación
  • Jiguet-Jiglaire C; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
  • Boissonneau S; APHM, CHU Timone, Service d'anatomopathologie, Marseille, France.
  • Denicolai E; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
  • Hein V; Department of Neursurgery, CHU Timone, Aix Marseille University, APHM, INSERM, MMG, Marseille, France.
  • Lasseur R; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
  • Garcia J; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
  • Romain S; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
  • Appay R; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Graillon T; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
  • Mason W; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
  • Carpentier AF; APHM, CHU Timone, Service d'anatomopathologie, Marseille, France.
  • Brandes AA; Department of Neursurgery, CHU Timone, Aix Marseille University, APHM, INSERM, MMG, Marseille, France.
  • Ouafik L'; Princess Margaret Hospital, Toronto, Canada.
  • Wick W; APHP, Paris University, Hopital Saint-Louis, Paris, France.
  • Baaziz A; Azienda AUSL- IRCCS-Istituto Scienze Neurologiche, Bologna, Italy.
  • Gigan JP; Aix-Marseille University, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
  • Argüello RJ; APHM, CHU Nord, Service d'Onco-Biologie, Marseille, France.
  • Figarella-Branger D; Heidelberg University Medical Center and German Cancer Research Center, Heidelberg, Germany.
  • Chinot O; Aix Marseille University, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
  • Tabouret E; Aix Marseille University, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
Acta Neuropathol Commun ; 10(1): 1, 2022 01 03.
Article en En | MEDLINE | ID: mdl-34980260
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma / Metaloproteinasa 9 de la Matriz / Inhibidores de la Angiogénesis / Bevacizumab / Neutrófilos Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Acta Neuropathol Commun Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma / Metaloproteinasa 9 de la Matriz / Inhibidores de la Angiogénesis / Bevacizumab / Neutrófilos Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Acta Neuropathol Commun Año: 2022 Tipo del documento: Article País de afiliación: Francia